Seyedeh Setareh Samaei, Mahshid Daryab, Sarah Gholami, Aryan Rezaee, Navid Fatehi, Romina Roshannia, Saeed Hashemi, Nazanin Javani, Parham Rahmanian, Reza Amani-Beni, Mohammad Arad Zandieh, Noushin Nabavi, Mohsen Rashidi, Neda Malgard, Mehrdad Hashemi, Afshin Taheriazam
Hepatocellular carcinoma (HCC) is the most prevalent type of liver cancer, mainly occurring in Asian countries with an increased incidence rate globally. Currently, several kinds of therapies have been deployed for HCC therapy including surgical resection, chemotherapy, radiotherapy and immunotherapy. However, this tumor is still incurable, requiring novel strategies for its treatment. The nanomedicine has provided the new insights regarding the treatment of cancer that liposomes as lipid-based nanoparticles, have been widely applied in cancer therapy due to their biocompaitiblity, high drug loading and ease of synthesis and modification...
April 30, 2024: Translational Oncology